








Kevin L. Cornwell - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Kevin L. Cornwell
Chairman, President, Chief Executive Officer and Secretary at Utah Medical Products, Inc.


View Full Profile
Are you Kevin L. Cornwell? Claim your profile


 


Sign up for Equilar Atlas and view Kevin L. Cornwell's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Kevin L. Cornwell's  network and community.
												FOLLOW changes in Kevin L. Cornwell's employment and money-in-motion.
												CONNECT with Kevin L. Cornwell through your network of contacts.
												








Kevin L. Cornwell's Executive Work History


Current


Chairman, President, Chief Executive Officer and Secretary, 
Utah Medical Products, Inc.


Past
To view Kevin L. Cornwell's complete executive work history, sign up now
Education


														 B.S., 
															Stanford University


														 M.S., 
															Stanford University


														 M.B.A., 
															Stanford University


Age
70

 
 


Kevin L. Cornwell's Biography



Chairman of UTMD since 1996.  President and CEO since December 1992. Secretary since 1993.  Has served in various senior operating management positions in several technology-based companies over a 40-year time span, including as a director on seven other company boards.  Received B.S. degree in Chemical Engineering from Stanford University, M.S. degree in Management Science from the Stanford Graduate School of Engineering, and MBA degree specializing in Finance and Operations Management from the Stanford Graduate School of Business. Among other personal and professional attributes, the board considers Mr. Cornwell's decades of strategic and o ...
(Read More)

			Chairman of UTMD since 1996.  President and CEO since December 1992. Secretary since 1993.  Has served in various senior operating management positions in several technology-based companies over a 40-year time span, including as a director on seven other company boards.  Received B.S. degree in Chemical Engineering from Stanford University, M.S. degree in Management Science from the Stanford Graduate School of Engineering, and MBA degree specializing in Finance and Operations Management from the Stanford Graduate School of Business. Among other personal and professional attributes, the board considers Mr. Cornwell's decades of strategic and operational experience in the medical device industry and the Company's many years of success and profitability under his guidance to be key reasons why he should continue as a member of the board.
		
Source: Utah Medical Products, Inc. on 03/10/2017
		
	

 






Sign up for Equilar Atlas and view Kevin L. Cornwell's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Kevin L. Cornwell. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Kevin L. Cornwell's  network and community.
												FOLLOW changes in Kevin L. Cornwell's employment and money-in-motion.
												CONNECT with Kevin L. Cornwell through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Kevin L. Cornwell


















Kevin L. Cornwell's Connections (6)





Sign up now to view Kevin L. Cornwell's 6 connections »









Paul O. Richins
Dir., Vice President, Principal Financial Officer, Chief Administrative Officer, Treasurer and Assistant Secretary, Utah Medical Products, Inc.









Barbara A. Payne
Former Board Member, Utah Medical Products, Inc.









Stephen W. Bennett
Former Board Member, Utah Medical Products, Inc.









Ernst G. Hoyer
Lead Independent Director, Utah Medical Products, Inc.









James H. Beeson
Board Member, Utah Medical Products, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
























 





UTMD Kevin L. Cornwell Insider Trades for Utah Medical Products Inc.


































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Utah Medical Products Inc.

                  NASDAQ: UTMD
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Utah Medical Products Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:33 p.m.


UTMD

/quotes/zigman/79558/composite


$
71.19




Change

-0.01
-0.02%

Volume
Volume 790
Quotes are delayed by 20 min








/quotes/zigman/79558/composite
Previous close

$
			72.30
		


$
				71.20
			
Change

-1.10
-1.52%





Day low
Day high
$71.00
$72.75










52 week low
52 week high

            $56.30
        

            $75.00
        


















Insider Activity


Individual




Kevin L. Cornwell



Mr. Kevin L. Cornwell is Chairman, President, CEO & Secretary at Utah Medical Products, Inc.
He received his undergraduate degree from Stanford University, a graduate degree from Stanford University, and an MBA from Stanford University.



Transactions


Date
Shares
Transaction
Value





12/12/2016
3,471


 
Disposition at $69.25 per share.


240,367


12/09/2016
60


 
Disposition at $69 per share.


4,140


12/08/2016
4,821


 
Disposition at $70.2 per share.


338,435


12/07/2016
465


 
Disposition at $69.05 per share.


32,109


11/30/2016
613


 
Disposition at $69 per share.


42,297


11/29/2016
664


 
Disposition at $69 per share.


45,816


11/28/2016
1,906


 
Disposition at $69.05 per share.


131,610


09/13/2016
1,396


 
Disposition at $63.09 per share.


88,074


09/07/2016
208


 
Disposition at $64.12 per share.


13,337


09/06/2016
200


 
Disposition at $64 per share.


12,800


08/31/2016
716


 
Disposition at $64.04 per share.


45,853


08/29/2016
2,200


 
Disposition at $64.7 per share.


142,340


08/15/2016
23


 
Disposition at $64 per share.


1,472


08/10/2016
1,800


 
Disposition at $64.13 per share.


115,434


11/10/2014
969


 
Disposition at $58.5 per share.


56,687


11/07/2014
2,503


 
Disposition at $58.5 per share.


146,426


03/10/2014
1,297


 
Disposition at $55.4 per share.


71,854


03/07/2014
1,200


 
Disposition at $55.5 per share.


66,600


03/06/2014
1,586


 
Disposition at $55.5 per share.


88,023


03/04/2014
1,098


 
Disposition at $55.96 per share.


61,445


02/26/2014
310


 
Disposition at $56.73 per share.


17,587


12/09/2013
1,235


 
Disposition at $51.63 per share.


63,764


12/06/2013
650


 
Disposition at $51.7 per share.


33,605


12/05/2013
400


 
Disposition at $51.5 per share.


20,600


12/04/2013
1,002


 
Disposition at $51.57 per share.


51,674


11/22/2013
2,169


 
Disposition at $53 per share.


114,957


11/21/2013
1,286


 
Disposition at $53.34 per share.


68,596


11/15/2013
900


 
Disposition at $56.28 per share.


50,652


11/13/2013
59


 
Disposition at $57.16 per share.


3,373


10/30/2013
57


 
Disposition at $55.43 per share.


3,160


10/29/2013
1,858


 
Disposition at $56.43 per share.


104,847


09/12/2013
1,169


 
Disposition at $50.5 per share.


59,035


09/11/2013
708


 
Disposition at $50.5 per share.


35,754


09/10/2013
2,759


 
Disposition at $50.5 per share.


139,330


08/23/2013
3,736


 
Disposition at $50.3 per share.


187,921


08/22/2013
1,979


 
Disposition at $50.33 per share.


99,604


08/13/2013
915


 
Disposition at $56.02 per share.


51,259


08/12/2013
97


 
Disposition at $56.6 per share.


5,491


08/08/2013
275


 
Disposition at $56.6 per share.


15,565


08/07/2013
343


 
Disposition at $56.8 per share.


19,483


08/05/2013
356


 
Disposition at $57.2 per share.


20,364


07/31/2013
3,100


 
Disposition at $57.59 per share.


178,529


07/30/2013
5,000


 
Disposition at $57.68 per share.


288,400


07/02/2013
10,000


 
Gift at $55.8 per share.


558,000


03/04/2013
10,000


 
Derivative/Non-derivative trans. at $25.59 per share.


255,900


03/04/2013
7,880


 
Derivative/Non-derivative trans. at $43.3 per share.


341,204


11/12/2012
12,000


 
Derivative/Non-derivative trans. at $25.59 per share.


307,080





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Kevin L. Cornwell 
Chairman, President, CEO & Secretary




Mr. Paul O. Richins 
Treasurer, Chief Financial & Accounting Officer




Dr. Barbara A. Payne 
Independent Director




Mr. Ernst G. Hoyer 
Lead Independent Director




Dr. James H. Beeson 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




6:48 AM EDT
July 24, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:48aStanley Black & Decker raises outlook after results beat views
6:40aOil prices advance as OPEC meeting unfolds
6:37aHasbro 2Q revenue $972.5 million vs. $878.9 million year ago
6:37aHasbro 2Q adjusted EPS 53 cents vs. 41 cents year ago
6:26aApple supplier Foxconn nearing decision about producing display panels in Wisconsin 
6:22aBlack swans? Here’s why the recent global breakout in stocks should NOT be trusted
6:07aStanley Black & Decker raises 2017 adj. EPS view to range of $7.18-$7.38 
6:06aStanley Black & Decker raises 2017 EPS view to range of $8.05-$8.25
6:05aStanley Black & Decker Q2 EPS ex-M&A charges was $2.01 
6:04aStanley Black & Decker Q2 revenue $3.23 bln vs. $2.93 bln year ago 
6:02aStanley Black & Decker Q2 EPS $1.82 vs. $1.84 year ago 
6:02aWhatever happened to inflation?
6:00aDrake still makes money from Degrassi–and so do these five other celebrities
5:58aAmerican workers are a slave to their emails — these digital organizers aim to help
5:42aU.S. stocks poised for soft start after IMF cuts growth forecast
5:38aPolish zloty rises as Poland's president plans veto for judicial revamp
5:23aBipartisan political squabbling over drug prices has already cost biotech companies $21 billion
5:21aInvesting according to your values can also make you money
5:20aHere’s how wealthy Americans keep the best for themselves
5:06aWhat is a long-term time horizon for older investors?
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
























































	
        Compensation Information for Kevin L. Cornwell , Chairman & CEO of UTAH MEDICAL PRODUCTS INC | Salary.com
    


























Enterprise
Small Business
Personal




Contact Us
Log In


































Salaries
Jobs
Education
Advice
























 





Kevin L. Cornwell 
Executive Compensation
As Chairman & CEO at UTAH MEDICAL PRODUCTS INC, Kevin L. Cornwell  made $445,910 in total compensation.  Of this total $156,000 was received as a salary, $282,450 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $7,460 came from other types of compensation. This information is according to proxy statements filed for the 2016 fiscal year. 


ENTER AN EXECUTIVE OR COMPANY NAME
New Search


Go



The chart on this page features a breakdown of the total annual pay for Kevin L. Cornwell ,  Chairman & CEO at UTAH MEDICAL PRODUCTS INC as reported in their proxy statements. 
Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. UTAH MEDICAL PRODUCTS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. UTAH MEDICAL PRODUCTS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.
Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.
Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.



Other Executives at this Company


Paul O. Richins 









Kevin L. Cornwell 


Base Pay$156,000
Bonus + Incentive Comp$282,450
Total Cash Compensation$438,450


Stock Award Value$0
Option Award Value$0
Total Equity$0



Total Other$7,460



Total Compensation$445,910




Browse Executives by First Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z


Browse Companies by Company Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#



This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. 
Use of Data / Disclaimer
The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.
What is a proxy statement?
A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.
The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.







    





 

 






     

privacy policy
terms of use
about us
contact us

©  Salary.com. All rights reserved.


US Salaries
Canadian Salaries
Purchase a Salary Report
Salaries by Category
Salaries by Income
Salaries by Industry
Popular Salaries
Negotiation Tips
Benefits Calculator
Search Job Openings
Job Openings by State
Job Openings by Category
Education by Career
Education by Level
Education by Major
Cost of Living Calculator
























 
   Kevin Cornwell | Utah Medical Products Inc | ZoomInfo.com










 













 


